Literature DB >> 16622994

The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months.

Ekasit Kowitdamrong1, Chitsanu Pancharoen, Rungtip Thammaborvorn, Parvapan Bhattarakosol.   

Abstract

The prevalence of varicella-zoster virus (VZV) infection was studied by determining the presence of IgG antibody to VZV (anti-VZV IgG) using ELISA method. Three hundred and fifty sera collected from Thai healthy individuals aged above 6 months (mean age +/- standard deviation = 14.9 +/- 11.4) were tested, the prevalence of VZV infection was 64.6% (225/350). All samples were randomly sampling from healthy children and blood donors who visited the hospital and clssified into 7 groups, 50 samples each, according to their age, i.e., group 1; 6 months-3 years, group 2; 4-6 years, group 3; 7-9 years, group 4; 10-14 years, group 5; 15-19 years, group 6; 20-24 years and group 7; above 25 years. The prevalence of VZV infection were 12%, 42%, 64%, 70%, 78%, 84% and 100% respectively. The mean amount of anti-VZV IgG among groups of positive VZV infection (225 samples) was 86.8 +/- 29.7 unit/ml. The mean amount of anti-VZV IgG was highest in 6 months-3 years age group (113.6 +/- 39.2 unit/ml). Significant difference of the mean amount of anti- VZV IgG was found between group 1, 3, 6 and other groups (p-value < 0.05). There was a correlation between history of varicella and the presence of anti-VZV IgG in the serum. 95.3% of individuals with positive history has already had the antibody. The important associated factors that might involve VZV infection were age, number of members in family and place of exposure to VZV infection. Other factors, such as sex and income did not show any association to VZV infection.

Entities:  

Mesh:

Year:  2005        PMID: 16622994

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  8 in total

Review 1.  Chickenpox: treatment.

Authors:  Jonathan Cohen; Judith Breuer
Journal:  BMJ Clin Evid       Date:  2015-06-15

2.  Herpes zoster in a 6-month-old infant with 13-year follow-up: a retrospective case report.

Authors:  Kristine J Aikenhead; Theodore L Johnson
Journal:  J Chiropr Med       Date:  2011-12

Review 3.  Chickenpox.

Authors:  George H Swingler
Journal:  BMJ Clin Evid       Date:  2007-08-01

Review 4.  Chickenpox.

Authors:  Judith Breuer; Helen Fifer
Journal:  BMJ Clin Evid       Date:  2011-04-11

Review 5.  Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy-case report and review of literature.

Authors:  Shishir Kumar; Shibu V Pillai
Journal:  Childs Nerv Syst       Date:  2019-02-25       Impact factor: 1.532

Review 6.  Disarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses.

Authors:  Dominik Schmiedel; Ofer Mandelboim
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

Review 7.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

Review 8.  Seroprevalence of ToRCH Pathogens in Southeast Asia.

Authors:  Franziska E Fuchs; Maude Pauly; Antony P Black; Judith M Hübschen
Journal:  Microorganisms       Date:  2021-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.